Fig. 3

Aurora Kinases overexpression render TNBC cells resistance to Paclitaxel treatment. (A) Immunoblotting (IB) analysis of AURKA, AURKB, and PLK1 in AA and EA TNBC cell lines. (B) Colony Formation assay analysis of indicated TNBC cells treated with chemotherapy drug Paclitaxel in indicated concentration.